Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Air Pollutants | 190 | 2024 | 2921 | 9.920 |
Why?
|
Particulate Matter | 187 | 2024 | 2623 | 8.870 |
Why?
|
Air Pollution | 131 | 2024 | 2379 | 8.220 |
Why?
|
Environmental Exposure | 145 | 2024 | 4544 | 6.080 |
Why?
|
Prenatal Exposure Delayed Effects | 60 | 2024 | 2538 | 3.950 |
Why?
|
Maternal Exposure | 49 | 2024 | 1097 | 3.900 |
Why?
|
Environmental Monitoring | 70 | 2021 | 1467 | 3.760 |
Why?
|
Environmental Pollutants | 24 | 2024 | 1294 | 3.180 |
Why?
|
Soot | 30 | 2024 | 219 | 2.940 |
Why?
|
Vehicle Emissions | 39 | 2019 | 651 | 2.920 |
Why?
|
Air Pollution, Indoor | 32 | 2025 | 930 | 2.620 |
Why?
|
Bayes Theorem | 45 | 2024 | 2352 | 2.480 |
Why?
|
Inhalation Exposure | 24 | 2020 | 432 | 2.160 |
Why?
|
Models, Statistical | 38 | 2023 | 5089 | 2.070 |
Why?
|
Respiratory Tract Diseases | 9 | 2019 | 744 | 1.570 |
Why?
|
Asthma | 35 | 2024 | 6267 | 1.560 |
Why?
|
Radon | 8 | 2025 | 90 | 1.490 |
Why?
|
Birth Weight | 24 | 2023 | 2123 | 1.400 |
Why?
|
Biostatistics | 4 | 2020 | 162 | 1.340 |
Why?
|
Biometry | 12 | 2016 | 571 | 1.290 |
Why?
|
Pregnancy | 123 | 2024 | 30235 | 1.290 |
Why?
|
DNA Methylation | 28 | 2023 | 4428 | 1.280 |
Why?
|
Particle Size | 51 | 2023 | 1634 | 1.280 |
Why?
|
Aircraft | 3 | 2019 | 135 | 1.270 |
Why?
|
Temperature | 18 | 2024 | 2229 | 1.220 |
Why?
|
Censuses | 7 | 2023 | 197 | 1.200 |
Why?
|
Linear Models | 41 | 2021 | 5872 | 1.190 |
Why?
|
Respiratory Sounds | 10 | 2022 | 702 | 1.180 |
Why?
|
Metals | 10 | 2023 | 711 | 1.160 |
Why?
|
Manganese | 12 | 2023 | 393 | 1.140 |
Why?
|
Air Pollutants, Radioactive | 7 | 2025 | 55 | 1.110 |
Why?
|
Occupational Diseases | 5 | 2018 | 1456 | 1.100 |
Why?
|
Radioactivity | 6 | 2023 | 60 | 1.100 |
Why?
|
Pulmonary Disease, Chronic Obstructive | 18 | 2024 | 3245 | 1.050 |
Why?
|
Boston | 68 | 2024 | 9333 | 1.050 |
Why?
|
Carbon | 17 | 2016 | 673 | 1.030 |
Why?
|
Fluorocarbons | 9 | 2023 | 498 | 0.990 |
Why?
|
Nitrogen Dioxide | 19 | 2024 | 538 | 0.930 |
Why?
|
Residence Characteristics | 20 | 2024 | 2114 | 0.910 |
Why?
|
Seasons | 31 | 2024 | 1521 | 0.900 |
Why?
|
Data Interpretation, Statistical | 16 | 2017 | 2693 | 0.900 |
Why?
|
Regression Analysis | 17 | 2018 | 6327 | 0.890 |
Why?
|
Humans | 449 | 2025 | 766432 | 0.870 |
Why?
|
Arsenic | 8 | 2022 | 357 | 0.870 |
Why?
|
Mortality | 19 | 2022 | 2907 | 0.810 |
Why?
|
Aerospace Medicine | 3 | 2018 | 95 | 0.800 |
Why?
|
Power Plants | 6 | 2011 | 125 | 0.780 |
Why?
|
Female | 284 | 2024 | 396354 | 0.780 |
Why?
|
Urban Population | 21 | 2023 | 2038 | 0.770 |
Why?
|
Male | 276 | 2024 | 363975 | 0.720 |
Why?
|
Massachusetts | 44 | 2024 | 8885 | 0.720 |
Why?
|
Housing | 14 | 2025 | 682 | 0.720 |
Why?
|
Aging | 32 | 2024 | 8725 | 0.700 |
Why?
|
Hydrocortisone | 8 | 2022 | 1838 | 0.700 |
Why?
|
Aerosols | 13 | 2018 | 634 | 0.690 |
Why?
|
Oxidative Stress | 20 | 2023 | 3141 | 0.690 |
Why?
|
Child Development | 10 | 2020 | 2327 | 0.670 |
Why?
|
Humidity | 5 | 2024 | 206 | 0.670 |
Why?
|
Lead | 10 | 2021 | 878 | 0.670 |
Why?
|
Population Groups | 1 | 2020 | 209 | 0.660 |
Why?
|
Socioeconomic Factors | 19 | 2024 | 7840 | 0.660 |
Why?
|
Environmental Health | 4 | 2018 | 297 | 0.630 |
Why?
|
Computer Simulation | 22 | 2023 | 6259 | 0.630 |
Why?
|
Homicide | 4 | 2017 | 294 | 0.620 |
Why?
|
Heart Rate | 19 | 2024 | 4190 | 0.610 |
Why?
|
Mexico | 16 | 2024 | 771 | 0.600 |
Why?
|
Aviation | 1 | 2018 | 49 | 0.600 |
Why?
|
Ozone | 14 | 2024 | 499 | 0.590 |
Why?
|
Schools | 8 | 2021 | 1495 | 0.590 |
Why?
|
Alkanesulfonic Acids | 6 | 2023 | 198 | 0.590 |
Why?
|
Hydrocarbons, Chlorinated | 4 | 2023 | 120 | 0.580 |
Why?
|
Health Surveys | 9 | 2019 | 4054 | 0.580 |
Why?
|
Blood Pressure | 17 | 2020 | 8532 | 0.570 |
Why?
|
DNA, Mitochondrial | 7 | 2021 | 872 | 0.570 |
Why?
|
Health Status Disparities | 7 | 2020 | 1876 | 0.560 |
Why?
|
Clothing | 1 | 2018 | 95 | 0.560 |
Why?
|
Pregnancy Outcome | 6 | 2024 | 2970 | 0.550 |
Why?
|
Cohort Studies | 69 | 2024 | 41703 | 0.550 |
Why?
|
Longitudinal Studies | 33 | 2021 | 14760 | 0.540 |
Why?
|
United States | 84 | 2025 | 72910 | 0.540 |
Why?
|
Infant, Newborn | 50 | 2024 | 26388 | 0.530 |
Why?
|
Aged | 139 | 2024 | 171234 | 0.530 |
Why?
|
Epigenesis, Genetic | 12 | 2024 | 3824 | 0.520 |
Why?
|
Poverty | 7 | 2024 | 2714 | 0.520 |
Why?
|
Tobacco Smoke Pollution | 2 | 2019 | 828 | 0.510 |
Why?
|
Polychlorinated Biphenyls | 3 | 2023 | 235 | 0.510 |
Why?
|
Flame Retardants | 3 | 2021 | 97 | 0.510 |
Why?
|
Cardiovascular Diseases | 20 | 2024 | 15639 | 0.510 |
Why?
|
Stress, Psychological | 13 | 2024 | 4527 | 0.500 |
Why?
|
Hypersensitivity | 5 | 2019 | 1169 | 0.500 |
Why?
|
Infant Mortality | 3 | 2015 | 752 | 0.500 |
Why?
|
Phthalic Acids | 5 | 2024 | 485 | 0.500 |
Why?
|
Vital Capacity | 8 | 2020 | 995 | 0.500 |
Why?
|
Occupational Exposure | 5 | 2019 | 1807 | 0.500 |
Why?
|
Arrhythmias, Cardiac | 10 | 2024 | 2246 | 0.490 |
Why?
|
Child | 80 | 2024 | 80668 | 0.490 |
Why?
|
Solar Activity | 4 | 2024 | 44 | 0.480 |
Why?
|
Airway Obstruction | 1 | 2020 | 672 | 0.480 |
Why?
|
Fetal Development | 7 | 2023 | 777 | 0.470 |
Why?
|
Prospective Studies | 61 | 2024 | 54826 | 0.460 |
Why?
|
Selection Bias | 1 | 2016 | 359 | 0.460 |
Why?
|
Endocrine Disruptors | 3 | 2024 | 264 | 0.460 |
Why?
|
Inflammation | 20 | 2024 | 10860 | 0.460 |
Why?
|
Models, Theoretical | 18 | 2019 | 3562 | 0.460 |
Why?
|
Epidemiology | 2 | 2018 | 278 | 0.450 |
Why?
|
Forced Expiratory Volume | 9 | 2020 | 1828 | 0.450 |
Why?
|
Cognition | 15 | 2024 | 7057 | 0.450 |
Why?
|
Violence | 3 | 2017 | 931 | 0.440 |
Why?
|
Human Rights Abuses | 1 | 2013 | 34 | 0.430 |
Why?
|
Dibutyl Phthalate | 3 | 2018 | 29 | 0.430 |
Why?
|
Abortion, Legal | 1 | 2015 | 121 | 0.430 |
Why?
|
Adult | 125 | 2024 | 223253 | 0.430 |
Why?
|
Lung | 17 | 2022 | 10064 | 0.430 |
Why?
|
Young Adult | 64 | 2024 | 59928 | 0.420 |
Why?
|
Causality | 3 | 2021 | 1251 | 0.420 |
Why?
|
Infant | 41 | 2024 | 36460 | 0.410 |
Why?
|
Urban Health | 8 | 2020 | 532 | 0.410 |
Why?
|
Healthcare Disparities | 2 | 2020 | 3403 | 0.410 |
Why?
|
Veterans | 8 | 2022 | 2667 | 0.400 |
Why?
|
Middle Aged | 113 | 2024 | 223127 | 0.390 |
Why?
|
Sulfates | 9 | 2017 | 380 | 0.390 |
Why?
|
Environment | 4 | 2019 | 1120 | 0.390 |
Why?
|
Cities | 11 | 2020 | 542 | 0.390 |
Why?
|
Adolescent | 68 | 2024 | 88898 | 0.390 |
Why?
|
Social Justice | 2 | 2024 | 483 | 0.390 |
Why?
|
Autonomic Nervous System | 4 | 2019 | 705 | 0.380 |
Why?
|
Population Dynamics | 1 | 2013 | 314 | 0.380 |
Why?
|
Menarche | 2 | 2024 | 532 | 0.380 |
Why?
|
Hazardous Substances | 3 | 2017 | 153 | 0.370 |
Why?
|
Body Mass Index | 11 | 2024 | 13045 | 0.360 |
Why?
|
Epigenomics | 4 | 2024 | 959 | 0.360 |
Why?
|
Aged, 80 and over | 67 | 2024 | 59538 | 0.350 |
Why?
|
Remote Sensing Technology | 4 | 2017 | 93 | 0.350 |
Why?
|
Premature Birth | 6 | 2024 | 1830 | 0.350 |
Why?
|
Child, Preschool | 43 | 2024 | 42576 | 0.340 |
Why?
|
Hot Temperature | 5 | 2023 | 1442 | 0.340 |
Why?
|
Privacy | 2 | 2023 | 233 | 0.340 |
Why?
|
Temperament | 3 | 2024 | 300 | 0.340 |
Why?
|
Toxicity Tests | 6 | 2011 | 112 | 0.330 |
Why?
|
Gamma Rays | 3 | 2020 | 324 | 0.330 |
Why?
|
Radiation Monitoring | 4 | 2025 | 106 | 0.330 |
Why?
|
Phenytoin | 6 | 2005 | 189 | 0.330 |
Why?
|
Depression | 13 | 2023 | 8229 | 0.330 |
Why?
|
Dust | 9 | 2024 | 489 | 0.330 |
Why?
|
Infant, Low Birth Weight | 4 | 2019 | 870 | 0.330 |
Why?
|
Coal | 7 | 2023 | 123 | 0.320 |
Why?
|
Colorectal Neoplasms | 2 | 2022 | 6962 | 0.320 |
Why?
|
Hair | 5 | 2020 | 508 | 0.320 |
Why?
|
Carbon Monoxide | 8 | 2019 | 560 | 0.320 |
Why?
|
Skin Diseases | 1 | 2018 | 1083 | 0.320 |
Why?
|
Maternal-Fetal Exchange | 3 | 2021 | 453 | 0.320 |
Why?
|
Oxidants, Photochemical | 3 | 2017 | 77 | 0.320 |
Why?
|
Spacecraft | 4 | 2017 | 28 | 0.310 |
Why?
|
United States Environmental Protection Agency | 8 | 2020 | 139 | 0.310 |
Why?
|
Metals, Heavy | 2 | 2016 | 149 | 0.310 |
Why?
|
Endothelium | 3 | 2020 | 768 | 0.310 |
Why?
|
Hypertension | 10 | 2020 | 8614 | 0.310 |
Why?
|
Cross-Over Studies | 12 | 2019 | 2108 | 0.310 |
Why?
|
Nutrition Surveys | 6 | 2023 | 1735 | 0.310 |
Why?
|
New England | 8 | 2023 | 1059 | 0.310 |
Why?
|
Nails | 6 | 2022 | 298 | 0.300 |
Why?
|
Food Supply | 2 | 2024 | 544 | 0.300 |
Why?
|
Family Characteristics | 5 | 2023 | 1001 | 0.300 |
Why?
|
Endotoxins | 3 | 2015 | 519 | 0.300 |
Why?
|
Menstrual Cycle | 4 | 2024 | 539 | 0.300 |
Why?
|
Mercury | 3 | 2022 | 289 | 0.300 |
Why?
|
Live Birth | 2 | 2023 | 516 | 0.300 |
Why?
|
Epidemiologic Studies | 4 | 2023 | 677 | 0.300 |
Why?
|
Gestational Age | 12 | 2023 | 3617 | 0.290 |
Why?
|
Hospitalization | 8 | 2024 | 10812 | 0.290 |
Why?
|
Abnormalities, Drug-Induced | 7 | 2005 | 337 | 0.290 |
Why?
|
Phenols | 2 | 2024 | 526 | 0.290 |
Why?
|
Sex Factors | 20 | 2021 | 10614 | 0.280 |
Why?
|
Income | 5 | 2015 | 1875 | 0.280 |
Why?
|
Statistics as Topic | 2 | 2011 | 2351 | 0.270 |
Why?
|
Dogs | 10 | 2017 | 3834 | 0.270 |
Why?
|
Automobiles | 2 | 2018 | 103 | 0.270 |
Why?
|
Geologic Sediments | 2 | 2004 | 81 | 0.270 |
Why?
|
Cause of Death | 5 | 2020 | 3714 | 0.270 |
Why?
|
Bone Density | 4 | 2020 | 3491 | 0.260 |
Why?
|
Fetal Blood | 7 | 2019 | 1366 | 0.260 |
Why?
|
Noise, Transportation | 2 | 2018 | 60 | 0.260 |
Why?
|
Police | 2 | 2019 | 158 | 0.260 |
Why?
|
Vitamin B Complex | 2 | 2019 | 299 | 0.260 |
Why?
|
Cough | 2 | 2024 | 599 | 0.260 |
Why?
|
Cross-Sectional Studies | 24 | 2024 | 26294 | 0.260 |
Why?
|
Infertility, Female | 2 | 2024 | 763 | 0.250 |
Why?
|
Epidemiologic Methods | 3 | 2008 | 1326 | 0.250 |
Why?
|
Decanoic Acids | 3 | 2021 | 68 | 0.250 |
Why?
|
Prenatal Care | 1 | 2013 | 1158 | 0.250 |
Why?
|
Intercellular Adhesion Molecule-1 | 8 | 2016 | 1131 | 0.240 |
Why?
|
Respiratory Function Tests | 11 | 2020 | 1691 | 0.240 |
Why?
|
Cluster Analysis | 7 | 2020 | 2718 | 0.240 |
Why?
|
Obesity | 9 | 2024 | 13088 | 0.240 |
Why?
|
Fertilization in Vitro | 3 | 2019 | 1301 | 0.240 |
Why?
|
Folic Acid | 4 | 2023 | 1337 | 0.240 |
Why?
|
Prevalence | 10 | 2019 | 15820 | 0.240 |
Why?
|
Fibrinogen | 5 | 2017 | 893 | 0.240 |
Why?
|
Mass Media | 2 | 2017 | 302 | 0.230 |
Why?
|
Disease Susceptibility | 3 | 2010 | 1791 | 0.230 |
Why?
|
Smoke | 3 | 2016 | 243 | 0.230 |
Why?
|
Population Surveillance | 3 | 2014 | 2594 | 0.230 |
Why?
|
Risk Factors | 41 | 2024 | 74828 | 0.230 |
Why?
|
Adult Survivors of Child Abuse | 2 | 2019 | 301 | 0.230 |
Why?
|
Incidence | 14 | 2024 | 21509 | 0.230 |
Why?
|
Bangladesh | 5 | 2019 | 745 | 0.230 |
Why?
|
Benzophenones | 1 | 2024 | 58 | 0.230 |
Why?
|
Ventricular Premature Complexes | 3 | 2023 | 108 | 0.220 |
Why?
|
Myocardial Ischemia | 6 | 2024 | 2127 | 0.220 |
Why?
|
Telomere | 4 | 2023 | 941 | 0.220 |
Why?
|
Cooking | 6 | 2016 | 327 | 0.220 |
Why?
|
Saliva | 4 | 2019 | 852 | 0.220 |
Why?
|
Time Factors | 28 | 2024 | 40116 | 0.210 |
Why?
|
Logistic Models | 13 | 2021 | 13276 | 0.210 |
Why?
|
Heart | 6 | 2019 | 4421 | 0.210 |
Why?
|
Copper | 2 | 2023 | 365 | 0.210 |
Why?
|
Water Pollutants, Chemical | 4 | 2017 | 356 | 0.210 |
Why?
|
Adipokines | 2 | 2017 | 308 | 0.210 |
Why?
|
Anticonvulsants | 5 | 2005 | 1920 | 0.210 |
Why?
|
Weather | 5 | 2019 | 234 | 0.210 |
Why?
|
Myocardial Infarction | 14 | 2022 | 11501 | 0.210 |
Why?
|
Leukocytes | 4 | 2022 | 2033 | 0.210 |
Why?
|
Executive Function | 3 | 2022 | 1396 | 0.210 |
Why?
|
Stroke | 11 | 2023 | 9732 | 0.210 |
Why?
|
Caprylates | 2 | 2021 | 113 | 0.200 |
Why?
|
Nickel | 2 | 2020 | 126 | 0.200 |
Why?
|
Tooth | 2 | 2021 | 210 | 0.200 |
Why?
|
Fetal Growth Retardation | 3 | 2017 | 591 | 0.200 |
Why?
|
Arsenicals | 2 | 2019 | 117 | 0.200 |
Why?
|
Pregnancy Complications | 5 | 2020 | 2971 | 0.200 |
Why?
|
Mesalamine | 3 | 2018 | 133 | 0.200 |
Why?
|
Mumps | 1 | 2023 | 71 | 0.200 |
Why?
|
Radiation Injuries | 2 | 2020 | 1192 | 0.200 |
Why?
|
Social Class | 6 | 2016 | 2006 | 0.190 |
Why?
|
Leukocyte Count | 2 | 2020 | 1606 | 0.190 |
Why?
|
Malus | 1 | 2022 | 51 | 0.190 |
Why?
|
Rodent Control | 1 | 2021 | 15 | 0.190 |
Why?
|
Beta Particles | 2 | 2020 | 52 | 0.190 |
Why?
|
Facial Bones | 1 | 2003 | 209 | 0.190 |
Why?
|
Women's Health | 6 | 2023 | 2080 | 0.190 |
Why?
|
Seawater | 3 | 2016 | 126 | 0.190 |
Why?
|
Nitrates | 2 | 2017 | 260 | 0.190 |
Why?
|
Sulfur | 2 | 2017 | 158 | 0.190 |
Why?
|
Cerebrovascular Disorders | 5 | 2024 | 1478 | 0.190 |
Why?
|
Anti-Inflammatory Agents, Non-Steroidal | 4 | 2020 | 2270 | 0.190 |
Why?
|
Parabens | 2 | 2024 | 117 | 0.190 |
Why?
|
Randomized Controlled Trials as Topic | 3 | 2024 | 10379 | 0.190 |
Why?
|
Italy | 5 | 2023 | 855 | 0.180 |
Why?
|
Nurses | 2 | 2023 | 2503 | 0.180 |
Why?
|
Satellite Communications | 3 | 2015 | 13 | 0.180 |
Why?
|
Pollen | 1 | 2001 | 80 | 0.180 |
Why?
|
Aging, Premature | 1 | 2021 | 44 | 0.180 |
Why?
|
Hypothalamo-Hypophyseal System | 3 | 2022 | 702 | 0.180 |
Why?
|
Pregnancy Trimesters | 2 | 2023 | 197 | 0.180 |
Why?
|
Vascular Cell Adhesion Molecule-1 | 4 | 2018 | 692 | 0.180 |
Why?
|
Allergens | 4 | 2021 | 1436 | 0.180 |
Why?
|
Lymphocyte Count | 2 | 2020 | 794 | 0.180 |
Why?
|
Tooth, Deciduous | 2 | 2018 | 76 | 0.180 |
Why?
|
Glutathione S-Transferase pi | 2 | 2018 | 99 | 0.180 |
Why?
|
Interleukin-6 | 7 | 2024 | 3226 | 0.180 |
Why?
|
Artificial Intelligence | 1 | 2015 | 2660 | 0.170 |
Why?
|
Electrocardiography, Ambulatory | 6 | 2009 | 579 | 0.170 |
Why?
|
Glutathione Transferase | 4 | 2019 | 565 | 0.170 |
Why?
|
Intelligence | 3 | 2020 | 925 | 0.170 |
Why?
|
Likelihood Functions | 5 | 2011 | 993 | 0.170 |
Why?
|
Paternal Exposure | 1 | 2020 | 100 | 0.170 |
Why?
|
United States Department of Veterans Affairs | 6 | 2017 | 937 | 0.170 |
Why?
|
Pesticides | 1 | 2022 | 297 | 0.170 |
Why?
|
Sample Size | 3 | 2023 | 844 | 0.170 |
Why?
|
Hemodynamics | 3 | 2015 | 4187 | 0.170 |
Why?
|
Mining | 2 | 2017 | 93 | 0.170 |
Why?
|
Selenium | 1 | 2022 | 418 | 0.170 |
Why?
|
Polycystic Ovary Syndrome | 1 | 2024 | 391 | 0.170 |
Why?
|
Blood Glucose | 3 | 2021 | 6422 | 0.160 |
Why?
|
ROC Curve | 3 | 2003 | 3616 | 0.160 |
Why?
|
Quinolinic Acid | 1 | 2019 | 67 | 0.160 |
Why?
|
Odds Ratio | 12 | 2021 | 9654 | 0.160 |
Why?
|
Pregnancy Trimester, Third | 2 | 2019 | 587 | 0.160 |
Why?
|
Leiomyoma | 1 | 2024 | 644 | 0.160 |
Why?
|
Vitamin B 6 | 2 | 2017 | 237 | 0.160 |
Why?
|
Meconium | 1 | 2019 | 47 | 0.160 |
Why?
|
Plant Proteins | 1 | 2001 | 375 | 0.160 |
Why?
|
Rats | 18 | 2019 | 23718 | 0.160 |
Why?
|
Dehydroepiandrosterone | 1 | 2019 | 249 | 0.160 |
Why?
|
Models, Biological | 6 | 2012 | 9458 | 0.150 |
Why?
|
Age Factors | 17 | 2024 | 18395 | 0.150 |
Why?
|
Rats, Sprague-Dawley | 15 | 2017 | 8107 | 0.150 |
Why?
|
Postmenopause | 2 | 2019 | 2517 | 0.150 |
Why?
|
Abortion, Spontaneous | 1 | 2023 | 536 | 0.150 |
Why?
|
Climate | 1 | 2019 | 146 | 0.150 |
Why?
|
Parturition | 2 | 2023 | 453 | 0.150 |
Why?
|
Risk | 11 | 2019 | 9601 | 0.150 |
Why?
|
Skull | 1 | 2003 | 819 | 0.150 |
Why?
|
Alloys | 1 | 2018 | 110 | 0.150 |
Why?
|
Infant, Small for Gestational Age | 2 | 2018 | 468 | 0.150 |
Why?
|
Diabetes Mellitus, Type 2 | 6 | 2023 | 12236 | 0.150 |
Why?
|
Diabetes, Gestational | 3 | 2024 | 1263 | 0.150 |
Why?
|
Geography | 3 | 2015 | 651 | 0.150 |
Why?
|
Insulin Resistance | 2 | 2023 | 3989 | 0.150 |
Why?
|
Ultrasonography, Prenatal | 2 | 2023 | 1772 | 0.150 |
Why?
|
Alaska | 1 | 2018 | 68 | 0.150 |
Why?
|
Dentin | 1 | 2018 | 75 | 0.150 |
Why?
|
Body Composition | 2 | 2018 | 2441 | 0.150 |
Why?
|
Calibration | 6 | 2022 | 814 | 0.150 |
Why?
|
Baroreflex | 2 | 2017 | 153 | 0.150 |
Why?
|
Depression, Postpartum | 1 | 2022 | 354 | 0.150 |
Why?
|
Wood | 2 | 2015 | 94 | 0.150 |
Why?
|
Gonadal Hormones | 1 | 2017 | 29 | 0.150 |
Why?
|
Gonadotropins, Pituitary | 1 | 2017 | 70 | 0.150 |
Why?
|
Confidence Intervals | 4 | 2019 | 2920 | 0.150 |
Why?
|
Reproductive Techniques, Assisted | 2 | 2019 | 503 | 0.150 |
Why?
|
Plasticizers | 1 | 2017 | 52 | 0.140 |
Why?
|
Neutrophils | 5 | 2020 | 3782 | 0.140 |
Why?
|
Pest Control | 1 | 2017 | 29 | 0.140 |
Why?
|
Endocrine Glands | 1 | 2017 | 101 | 0.140 |
Why?
|
Hypospadias | 1 | 2018 | 98 | 0.140 |
Why?
|
Ecosystem | 1 | 2021 | 489 | 0.140 |
Why?
|
Cryptorchidism | 1 | 2018 | 152 | 0.140 |
Why?
|
Vitamin B 12 | 2 | 2017 | 531 | 0.140 |
Why?
|
Child Behavior | 2 | 2020 | 864 | 0.140 |
Why?
|
Genome, Mitochondrial | 1 | 2017 | 68 | 0.140 |
Why?
|
Iron | 2 | 2023 | 1812 | 0.140 |
Why?
|
Patient Admission | 2 | 2015 | 1364 | 0.140 |
Why?
|
Fungi | 2 | 2022 | 346 | 0.140 |
Why?
|
Binomial Distribution | 1 | 1996 | 23 | 0.140 |
Why?
|
Basal Metabolism | 1 | 2018 | 163 | 0.140 |
Why?
|
Models, Cardiovascular | 2 | 2020 | 977 | 0.140 |
Why?
|
Pre-Eclampsia | 2 | 2024 | 1256 | 0.140 |
Why?
|
Halogenated Diphenyl Ethers | 3 | 2021 | 84 | 0.140 |
Why?
|
Death Certificates | 1 | 2017 | 172 | 0.130 |
Why?
|
C-Reactive Protein | 9 | 2024 | 3852 | 0.130 |
Why?
|
Guideline Adherence | 2 | 2005 | 2233 | 0.130 |
Why?
|
Phenobarbital | 5 | 2005 | 192 | 0.130 |
Why?
|
Herbicides | 1 | 2017 | 104 | 0.130 |
Why?
|
Folic Acid Deficiency | 1 | 2017 | 117 | 0.130 |
Why?
|
Environment Design | 1 | 2018 | 174 | 0.130 |
Why?
|
Cosmetics | 1 | 2017 | 104 | 0.130 |
Why?
|
Animals | 39 | 2022 | 168887 | 0.130 |
Why?
|
Law Enforcement | 1 | 2017 | 112 | 0.130 |
Why?
|
Dinoprost | 1 | 2016 | 139 | 0.130 |
Why?
|
Los Angeles | 3 | 2011 | 244 | 0.130 |
Why?
|
Nitrogen Oxides | 4 | 2017 | 128 | 0.130 |
Why?
|
Cold Temperature | 2 | 2017 | 795 | 0.130 |
Why?
|
Thyroid Hormones | 1 | 2018 | 408 | 0.120 |
Why?
|
Analgesics, Non-Narcotic | 1 | 2019 | 371 | 0.120 |
Why?
|
Smoking | 5 | 2019 | 9076 | 0.120 |
Why?
|
Developing Countries | 2 | 2018 | 2913 | 0.120 |
Why?
|
Rural Health | 1 | 2017 | 302 | 0.120 |
Why?
|
Language Development | 1 | 2016 | 183 | 0.120 |
Why?
|
Renal Insufficiency | 1 | 2021 | 810 | 0.120 |
Why?
|
Postpartum Period | 2 | 2022 | 1195 | 0.120 |
Why?
|
Meningomyelocele | 1 | 2017 | 182 | 0.120 |
Why?
|
Insecticides | 1 | 2017 | 203 | 0.120 |
Why?
|
Sperm Motility | 1 | 2016 | 264 | 0.120 |
Why?
|
Emigrants and Immigrants | 1 | 2022 | 550 | 0.120 |
Why?
|
Hypothyroidism | 1 | 2020 | 665 | 0.120 |
Why?
|
Georgia | 2 | 2013 | 186 | 0.120 |
Why?
|
Hypertension, Pregnancy-Induced | 2 | 2024 | 530 | 0.120 |
Why?
|
Polychaeta | 2 | 2004 | 5 | 0.120 |
Why?
|
Nasal Mucosa | 1 | 2018 | 416 | 0.120 |
Why?
|
Fingers | 5 | 2005 | 508 | 0.120 |
Why?
|
Optical Phenomena | 1 | 2015 | 103 | 0.120 |
Why?
|
Brugada Syndrome | 1 | 2016 | 96 | 0.120 |
Why?
|
Acetaminophen | 1 | 2019 | 549 | 0.120 |
Why?
|
Minority Health | 1 | 2015 | 79 | 0.120 |
Why?
|
Pregnant Women | 2 | 2018 | 576 | 0.120 |
Why?
|
Respiration | 2 | 2011 | 1653 | 0.120 |
Why?
|
Diet, Reducing | 1 | 2018 | 487 | 0.120 |
Why?
|
beta-Glucans | 1 | 2015 | 129 | 0.110 |
Why?
|
Immunoglobulin E | 4 | 2018 | 1495 | 0.110 |
Why?
|
Nervous System | 1 | 2017 | 542 | 0.110 |
Why?
|
Normal Distribution | 1 | 2014 | 267 | 0.110 |
Why?
|
Cerebrovascular Circulation | 2 | 2015 | 2672 | 0.110 |
Why?
|
Proportional Hazards Models | 10 | 2020 | 12527 | 0.110 |
Why?
|
Aortic Aneurysm, Abdominal | 1 | 2024 | 1249 | 0.110 |
Why?
|
Follow-Up Studies | 11 | 2019 | 39283 | 0.110 |
Why?
|
Insulin-Secreting Cells | 1 | 2021 | 899 | 0.110 |
Why?
|
Glucose Intolerance | 2 | 2018 | 578 | 0.110 |
Why?
|
Psychotic Disorders | 2 | 2022 | 3275 | 0.110 |
Why?
|
Semen | 1 | 2016 | 349 | 0.110 |
Why?
|
School Health Services | 1 | 2017 | 388 | 0.110 |
Why?
|
Radon Daughters | 2 | 2023 | 11 | 0.110 |
Why?
|
MicroRNAs | 2 | 2022 | 3788 | 0.110 |
Why?
|
Coronary Artery Disease | 5 | 2016 | 6543 | 0.110 |
Why?
|
Erectile Dysfunction | 1 | 2017 | 437 | 0.110 |
Why?
|
Coronary Circulation | 2 | 2010 | 1601 | 0.110 |
Why?
|
Models, Genetic | 2 | 2020 | 3450 | 0.110 |
Why?
|
Educational Status | 3 | 2018 | 2510 | 0.110 |
Why?
|
Neoplasms | 3 | 2020 | 22343 | 0.110 |
Why?
|
Subcutaneous Fat | 1 | 2016 | 401 | 0.110 |
Why?
|
Life Change Events | 2 | 2015 | 956 | 0.100 |
Why?
|
Firearms | 2 | 2017 | 630 | 0.100 |
Why?
|
Parasympathetic Nervous System | 1 | 2013 | 144 | 0.100 |
Why?
|
Cockroaches | 2 | 2017 | 92 | 0.100 |
Why?
|
Peroxidase | 1 | 2016 | 610 | 0.100 |
Why?
|
Stress, Physiological | 2 | 2017 | 1404 | 0.100 |
Why?
|
Colombia | 1 | 2013 | 288 | 0.100 |
Why?
|
Data Collection | 3 | 2021 | 3321 | 0.100 |
Why?
|
Rural Population | 4 | 2021 | 2317 | 0.100 |
Why?
|
Climate Change | 1 | 2019 | 509 | 0.100 |
Why?
|
Civil Rights | 1 | 2013 | 129 | 0.100 |
Why?
|
Toes | 2 | 2005 | 209 | 0.100 |
Why?
|
Sex Characteristics | 3 | 2018 | 2645 | 0.100 |
Why?
|
SEER Program | 2 | 2015 | 1443 | 0.100 |
Why?
|
Inflammation Mediators | 3 | 2017 | 1889 | 0.100 |
Why?
|
Brachial Artery | 1 | 2014 | 373 | 0.100 |
Why?
|
Placenta | 2 | 2023 | 1725 | 0.100 |
Why?
|
Bronchoalveolar Lavage Fluid | 3 | 2011 | 755 | 0.100 |
Why?
|
Longevity | 1 | 2019 | 1085 | 0.100 |
Why?
|
Retroelements | 1 | 2013 | 163 | 0.100 |
Why?
|
Transition Elements | 1 | 2011 | 14 | 0.100 |
Why?
|
Self Report | 3 | 2019 | 3770 | 0.100 |
Why?
|
Adiposity | 2 | 2019 | 1892 | 0.090 |
Why?
|
Medicare | 8 | 2024 | 6817 | 0.090 |
Why?
|
Cardiomyopathies | 1 | 2024 | 2041 | 0.090 |
Why?
|
Alkanes | 1 | 2011 | 39 | 0.090 |
Why?
|
Brain Ischemia | 3 | 2013 | 3000 | 0.090 |
Why?
|
Fatty Acids, Omega-3 | 2 | 2019 | 1398 | 0.090 |
Why?
|
Silicones | 2 | 2022 | 228 | 0.090 |
Why?
|
State Health Plans | 1 | 2013 | 220 | 0.090 |
Why?
|
Fatty Liver | 1 | 2017 | 810 | 0.090 |
Why?
|
Macrophages, Alveolar | 2 | 2006 | 413 | 0.090 |
Why?
|
Software | 2 | 2018 | 4464 | 0.090 |
Why?
|
Mothers | 5 | 2018 | 2208 | 0.090 |
Why?
|
Verbal Learning | 2 | 2023 | 459 | 0.090 |
Why?
|
Probability | 3 | 2023 | 2475 | 0.090 |
Why?
|
Analysis of Variance | 2 | 2016 | 6212 | 0.090 |
Why?
|
Fatigue | 1 | 2018 | 1554 | 0.090 |
Why?
|
Stachybotrys | 1 | 2010 | 1 | 0.090 |
Why?
|
Maximal Midexpiratory Flow Rate | 2 | 2020 | 75 | 0.090 |
Why?
|
Sympathetic Nervous System | 1 | 2013 | 520 | 0.090 |
Why?
|
Wechsler Scales | 2 | 2021 | 256 | 0.090 |
Why?
|
Endothelial Cells | 3 | 2018 | 3576 | 0.090 |
Why?
|
Students | 2 | 2017 | 1742 | 0.090 |
Why?
|
Congenital Abnormalities | 2 | 2014 | 703 | 0.090 |
Why?
|
Genome-Wide Association Study | 3 | 2019 | 12807 | 0.090 |
Why?
|
Southeastern United States | 3 | 2015 | 94 | 0.090 |
Why?
|
Single-Blind Method | 4 | 2017 | 1587 | 0.090 |
Why?
|
Case-Control Studies | 7 | 2018 | 22245 | 0.090 |
Why?
|
Mycotoxins | 1 | 2010 | 35 | 0.090 |
Why?
|
Propensity Score | 2 | 2021 | 1972 | 0.090 |
Why?
|
Promoter Regions, Genetic | 4 | 2014 | 5789 | 0.080 |
Why?
|
Lectins | 1 | 2012 | 490 | 0.080 |
Why?
|
Risk Assessment | 12 | 2020 | 24272 | 0.080 |
Why?
|
Methylmercury Compounds | 1 | 2011 | 103 | 0.080 |
Why?
|
Alabama | 2 | 2024 | 111 | 0.080 |
Why?
|
Sulfur Dioxide | 3 | 2019 | 178 | 0.080 |
Why?
|
Mitogen-Activated Protein Kinases | 1 | 2014 | 1243 | 0.080 |
Why?
|
Vasodilation | 1 | 2014 | 969 | 0.080 |
Why?
|
Echo-Planar Imaging | 1 | 2013 | 649 | 0.080 |
Why?
|
Exercise | 3 | 2023 | 5943 | 0.080 |
Why?
|
Databases, Factual | 5 | 2017 | 8061 | 0.080 |
Why?
|
Sulfonic Acids | 2 | 2021 | 103 | 0.080 |
Why?
|
Pilot Projects | 6 | 2019 | 8720 | 0.080 |
Why?
|
Electrocardiography | 8 | 2017 | 6378 | 0.080 |
Why?
|
Eligibility Determination | 1 | 2013 | 421 | 0.080 |
Why?
|
Aorta | 1 | 2017 | 2041 | 0.080 |
Why?
|
Visual Perception | 1 | 2017 | 1392 | 0.080 |
Why?
|
Antihypertensive Agents | 1 | 2018 | 2029 | 0.080 |
Why?
|
Epidemiologic Research Design | 1 | 2012 | 368 | 0.080 |
Why?
|
Evoked Potentials | 1 | 2015 | 1050 | 0.080 |
Why?
|
Uncertainty | 1 | 2014 | 764 | 0.080 |
Why?
|
Hypotension, Orthostatic | 1 | 2012 | 258 | 0.080 |
Why?
|
Fatty Acids | 3 | 2022 | 1807 | 0.080 |
Why?
|
Catalase | 3 | 2016 | 215 | 0.080 |
Why?
|
California | 2 | 2018 | 1435 | 0.080 |
Why?
|
Cell Count | 2 | 2011 | 1826 | 0.080 |
Why?
|
Memory Disorders | 1 | 2015 | 1193 | 0.080 |
Why?
|
Comparative Genomic Hybridization | 1 | 2009 | 474 | 0.080 |
Why?
|
Bronchitis | 3 | 2014 | 193 | 0.080 |
Why?
|
Nervous System Diseases | 1 | 2019 | 1659 | 0.080 |
Why?
|
Calcinosis | 1 | 2017 | 1478 | 0.080 |
Why?
|
Mitochondria | 1 | 2021 | 3676 | 0.070 |
Why?
|
Ventricular Function | 1 | 2010 | 403 | 0.070 |
Why?
|
Athletic Injuries | 1 | 2018 | 1244 | 0.070 |
Why?
|
Oxygen | 2 | 2014 | 4251 | 0.070 |
Why?
|
Glucose | 2 | 2017 | 4339 | 0.070 |
Why?
|
Population Density | 2 | 2018 | 193 | 0.070 |
Why?
|
Motor Vehicles | 1 | 2009 | 280 | 0.070 |
Why?
|
Cadmium | 2 | 2022 | 218 | 0.070 |
Why?
|
Microspheres | 2 | 2008 | 774 | 0.070 |
Why?
|
Independent Living | 1 | 2012 | 584 | 0.070 |
Why?
|
Heart Failure | 3 | 2024 | 11816 | 0.070 |
Why?
|
Insect Control | 1 | 2007 | 28 | 0.070 |
Why?
|
Nonlinear Dynamics | 1 | 2010 | 489 | 0.070 |
Why?
|
Tumor Necrosis Factor-alpha | 4 | 2012 | 4348 | 0.070 |
Why?
|
Infusions, Intra-Arterial | 1 | 2007 | 220 | 0.070 |
Why?
|
Postural Balance | 1 | 2012 | 637 | 0.070 |
Why?
|
DNA Damage | 1 | 2017 | 2464 | 0.070 |
Why?
|
Brain Concussion | 1 | 2018 | 1431 | 0.070 |
Why?
|
Sex | 2 | 2017 | 52 | 0.070 |
Why?
|
Reproducibility of Results | 10 | 2018 | 20129 | 0.070 |
Why?
|
Electronic Health Records | 2 | 2022 | 4879 | 0.070 |
Why?
|
Multivariate Analysis | 5 | 2019 | 12061 | 0.070 |
Why?
|
Reaction Time | 1 | 2013 | 2085 | 0.070 |
Why?
|
Systemic Inflammatory Response Syndrome | 1 | 2012 | 621 | 0.070 |
Why?
|
Overweight | 1 | 2018 | 2446 | 0.070 |
Why?
|
Histones | 1 | 2017 | 2591 | 0.070 |
Why?
|
Myocardium | 5 | 2011 | 4763 | 0.070 |
Why?
|
Methylation | 2 | 2019 | 1074 | 0.070 |
Why?
|
Ectromelia | 1 | 2006 | 28 | 0.070 |
Why?
|
Attention | 2 | 2015 | 2413 | 0.070 |
Why?
|
Histocompatibility Antigens Class I | 1 | 2013 | 1362 | 0.070 |
Why?
|
Leptin | 1 | 2014 | 1596 | 0.070 |
Why?
|
Weight Loss | 1 | 2018 | 2711 | 0.070 |
Why?
|
Respiratory Physiological Phenomena | 1 | 2007 | 191 | 0.070 |
Why?
|
Public Housing | 1 | 2007 | 140 | 0.060 |
Why?
|
Patella | 3 | 2016 | 317 | 0.060 |
Why?
|
Developmental Disabilities | 1 | 2014 | 1519 | 0.060 |
Why?
|
Breast Neoplasms | 3 | 2011 | 21157 | 0.060 |
Why?
|
Heart Diseases | 5 | 2014 | 2814 | 0.060 |
Why?
|
Glutamate-Cysteine Ligase | 2 | 2016 | 24 | 0.060 |
Why?
|
Teratogens | 2 | 2003 | 119 | 0.060 |
Why?
|
Pituitary-Adrenal System | 2 | 2022 | 553 | 0.060 |
Why?
|
Spirometry | 2 | 2022 | 929 | 0.060 |
Why?
|
Vitamin D | 1 | 2019 | 3270 | 0.060 |
Why?
|
Lung Diseases | 3 | 2007 | 1941 | 0.060 |
Why?
|
NAD(P)H Dehydrogenase (Quinone) | 2 | 2016 | 57 | 0.060 |
Why?
|
Macrophages | 2 | 2011 | 5782 | 0.060 |
Why?
|
Hypotension | 1 | 2011 | 887 | 0.060 |
Why?
|
Memory, Short-Term | 2 | 2022 | 1004 | 0.060 |
Why?
|
Diagnostic Techniques and Procedures | 1 | 2007 | 216 | 0.060 |
Why?
|
Ventricular Dysfunction | 1 | 2006 | 143 | 0.060 |
Why?
|
Venous Thrombosis | 1 | 2015 | 1321 | 0.060 |
Why?
|
Endothelium, Vascular | 1 | 2017 | 4417 | 0.060 |
Why?
|
Poverty Areas | 1 | 2006 | 268 | 0.060 |
Why?
|
Rain | 2 | 2003 | 60 | 0.060 |
Why?
|
Bronchitis, Chronic | 2 | 2002 | 81 | 0.060 |
Why?
|
Pregnancy Trimester, First | 2 | 2020 | 917 | 0.060 |
Why?
|
Nutritional Status | 2 | 2018 | 1621 | 0.060 |
Why?
|
Catheters, Indwelling | 1 | 2007 | 436 | 0.060 |
Why?
|
Wounds and Injuries | 1 | 2017 | 2513 | 0.060 |
Why?
|
Tibia | 3 | 2016 | 1071 | 0.060 |
Why?
|
Genetic Variation | 2 | 2017 | 6612 | 0.060 |
Why?
|
Carbanilides | 1 | 2024 | 18 | 0.060 |
Why?
|
Weight Gain | 1 | 2015 | 2356 | 0.060 |
Why?
|
HIV Infections | 3 | 2020 | 17534 | 0.060 |
Why?
|
Blood Pressure Determination | 2 | 2020 | 646 | 0.060 |
Why?
|
Ghana | 2 | 2017 | 333 | 0.060 |
Why?
|
Nitric Oxide | 2 | 2018 | 2141 | 0.060 |
Why?
|
Algorithms | 5 | 2019 | 14071 | 0.060 |
Why?
|
Biomass | 2 | 2015 | 135 | 0.060 |
Why?
|
Automobile Driving | 1 | 2009 | 442 | 0.060 |
Why?
|
Quality Control | 2 | 2005 | 834 | 0.060 |
Why?
|
Lymphocytes | 3 | 2019 | 2605 | 0.060 |
Why?
|
Heart Conduction System | 1 | 2009 | 991 | 0.060 |
Why?
|
Midwestern United States | 1 | 2023 | 70 | 0.060 |
Why?
|
Mid-Atlantic Region | 2 | 2014 | 24 | 0.060 |
Why?
|
Face | 3 | 2005 | 1029 | 0.050 |
Why?
|
Space-Time Clustering | 2 | 2016 | 45 | 0.050 |
Why?
|
Genes, Dominant | 1 | 2006 | 855 | 0.050 |
Why?
|
Bone and Bones | 2 | 2011 | 2559 | 0.050 |
Why?
|
Age Determination by Teeth | 1 | 2003 | 11 | 0.050 |
Why?
|
Cardiovascular System | 1 | 2011 | 838 | 0.050 |
Why?
|
Survival Rate | 2 | 2015 | 12825 | 0.050 |
Why?
|
Hexachlorobenzene | 1 | 2023 | 26 | 0.050 |
Why?
|
Androgens | 2 | 2022 | 1279 | 0.050 |
Why?
|
Ethmoid Bone | 1 | 2003 | 35 | 0.050 |
Why?
|
Complex Mixtures | 1 | 2022 | 29 | 0.050 |
Why?
|
Diffusion Tensor Imaging | 1 | 2013 | 2418 | 0.050 |
Why?
|
Diet Surveys | 1 | 2007 | 1159 | 0.050 |
Why?
|
Tooth Abnormalities | 1 | 2003 | 56 | 0.050 |
Why?
|
Menstruation Disturbances | 1 | 2024 | 140 | 0.050 |
Why?
|
Middle Cerebral Artery | 2 | 2015 | 271 | 0.050 |
Why?
|
Heme Oxygenase-1 | 2 | 2016 | 364 | 0.050 |
Why?
|
Radiography, Panoramic | 1 | 2003 | 110 | 0.050 |
Why?
|
Dichlorodiphenyl Dichloroethylene | 1 | 2023 | 85 | 0.050 |
Why?
|
Dermatoglyphics | 1 | 2002 | 20 | 0.050 |
Why?
|
Age Determination by Skeleton | 1 | 2003 | 124 | 0.050 |
Why?
|
Breath Tests | 2 | 2018 | 297 | 0.050 |
Why?
|
Swimming | 1 | 2003 | 212 | 0.050 |
Why?
|
Enterococcus | 1 | 2003 | 158 | 0.050 |
Why?
|
Medicaid | 2 | 2013 | 2834 | 0.050 |
Why?
|
Memory | 3 | 2017 | 2192 | 0.050 |
Why?
|
Arteries | 1 | 2007 | 1121 | 0.050 |
Why?
|
Sick Building Syndrome | 1 | 2021 | 17 | 0.050 |
Why?
|
CpG Islands | 2 | 2019 | 1208 | 0.050 |
Why?
|
Neurilemmoma | 1 | 2007 | 522 | 0.050 |
Why?
|
Disease Models, Animal | 8 | 2017 | 18322 | 0.050 |
Why?
|
Sleep Apnea Syndromes | 1 | 2010 | 983 | 0.050 |
Why?
|
Rodenticides | 1 | 2021 | 21 | 0.050 |
Why?
|
Follicle Stimulating Hormone | 1 | 2024 | 731 | 0.050 |
Why?
|
Lung Neoplasms | 2 | 2023 | 13486 | 0.050 |
Why?
|
Baltimore | 3 | 2007 | 233 | 0.050 |
Why?
|
Research Design | 5 | 2024 | 6205 | 0.050 |
Why?
|
Consciousness | 1 | 2007 | 602 | 0.050 |
Why?
|
Multicenter Studies as Topic | 3 | 2010 | 1732 | 0.050 |
Why?
|
Gene Dosage | 2 | 2020 | 1211 | 0.050 |
Why?
|
Tanzania | 2 | 2016 | 1406 | 0.050 |
Why?
|
Sex Distribution | 2 | 2017 | 2272 | 0.050 |
Why?
|
Fertilization | 1 | 2022 | 197 | 0.050 |
Why?
|
Cephalometry | 1 | 2003 | 380 | 0.050 |
Why?
|
Social Environment | 2 | 2017 | 1012 | 0.050 |
Why?
|
Nitric Oxide Synthase Type II | 2 | 2013 | 513 | 0.050 |
Why?
|
Neoplasm Staging | 1 | 2015 | 11217 | 0.040 |
Why?
|
Antioxidants | 3 | 2020 | 1671 | 0.040 |
Why?
|
Drug Combinations | 2 | 2006 | 2078 | 0.040 |
Why?
|
Polymorphism, Single Nucleotide | 3 | 2019 | 16042 | 0.040 |
Why?
|
Michigan | 1 | 2001 | 329 | 0.040 |
Why?
|
Least-Squares Analysis | 1 | 2021 | 368 | 0.040 |
Why?
|
Ethylene Glycol | 1 | 2000 | 31 | 0.040 |
Why?
|
Neuropsychological Tests | 3 | 2018 | 7119 | 0.040 |
Why?
|
Ferritins | 1 | 2023 | 600 | 0.040 |
Why?
|
Skull Base | 1 | 2003 | 294 | 0.040 |
Why?
|
Pliability | 1 | 2019 | 57 | 0.040 |
Why?
|
Ohio | 2 | 2014 | 320 | 0.040 |
Why?
|
Chromium | 1 | 2020 | 133 | 0.040 |
Why?
|
Reactive Oxygen Species | 2 | 2011 | 2143 | 0.040 |
Why?
|
Vasoconstriction | 1 | 2002 | 592 | 0.040 |
Why?
|
Problem Solving | 1 | 2022 | 442 | 0.040 |
Why?
|
Hospitals | 2 | 2024 | 3885 | 0.040 |
Why?
|
Maxilla | 1 | 2003 | 486 | 0.040 |
Why?
|
Anxiety | 3 | 2023 | 4671 | 0.040 |
Why?
|
Glioma | 2 | 2012 | 3498 | 0.040 |
Why?
|
Brain Mapping | 1 | 2015 | 6596 | 0.040 |
Why?
|
Numerical Analysis, Computer-Assisted | 1 | 2019 | 120 | 0.040 |
Why?
|
Esters | 1 | 2020 | 212 | 0.040 |
Why?
|
Lagomorpha | 1 | 1999 | 7 | 0.040 |
Why?
|
Emergency Service, Hospital | 3 | 2014 | 7869 | 0.040 |
Why?
|
Polytetrafluoroethylene | 1 | 2020 | 242 | 0.040 |
Why?
|
Cacodylic Acid | 1 | 2019 | 14 | 0.040 |
Why?
|
Luciferases | 1 | 2021 | 713 | 0.040 |
Why?
|
Fertility | 1 | 2024 | 770 | 0.040 |
Why?
|
Site-Specific DNA-Methyltransferase (Adenine-Specific) | 1 | 2019 | 18 | 0.040 |
Why?
|
Hospitals, Community | 3 | 1986 | 363 | 0.040 |
Why?
|
Sampling Studies | 1 | 2020 | 614 | 0.040 |
Why?
|
Trace Elements | 1 | 2020 | 193 | 0.040 |
Why?
|
Sensory Gating | 1 | 2019 | 47 | 0.040 |
Why?
|
Antifibrinolytic Agents | 1 | 1982 | 289 | 0.040 |
Why?
|
Pneumonia | 2 | 2002 | 2159 | 0.040 |
Why?
|
Patient Acceptance of Health Care | 1 | 2013 | 3230 | 0.040 |
Why?
|
Vitamins | 2 | 2023 | 1630 | 0.040 |
Why?
|
Natriuretic Peptide, Brain | 1 | 2007 | 1732 | 0.040 |
Why?
|
Canada | 2 | 2019 | 2123 | 0.040 |
Why?
|
Ultraviolet Rays | 1 | 2023 | 1101 | 0.040 |
Why?
|
Illinois | 1 | 2018 | 120 | 0.040 |
Why?
|
United States Occupational Safety and Health Administration | 1 | 2018 | 54 | 0.040 |
Why?
|
Geographic Information Systems | 2 | 2013 | 281 | 0.040 |
Why?
|
Glucose Tolerance Test | 1 | 2021 | 1180 | 0.040 |
Why?
|
Mandible | 1 | 2003 | 747 | 0.040 |
Why?
|
Phenotype | 4 | 2019 | 16721 | 0.040 |
Why?
|
Multilevel Analysis | 1 | 2018 | 148 | 0.040 |
Why?
|
India | 2 | 2015 | 2335 | 0.040 |
Why?
|
Vital Statistics | 1 | 2017 | 31 | 0.040 |
Why?
|
Air Conditioning | 1 | 2017 | 54 | 0.040 |
Why?
|
Stress Disorders, Post-Traumatic | 1 | 2015 | 4628 | 0.040 |
Why?
|
Rest | 2 | 2018 | 940 | 0.040 |
Why?
|
New Hampshire | 1 | 2017 | 174 | 0.040 |
Why?
|
Forecasting | 2 | 2019 | 2935 | 0.040 |
Why?
|
Brain | 2 | 2015 | 27156 | 0.040 |
Why?
|
Exercise Test | 1 | 2005 | 2185 | 0.040 |
Why?
|
Animals, Newborn | 1 | 2003 | 2675 | 0.040 |
Why?
|
Mites | 1 | 2017 | 46 | 0.030 |
Why?
|
Eosinophils | 1 | 2022 | 952 | 0.030 |
Why?
|
Regional Blood Flow | 2 | 2013 | 1478 | 0.030 |
Why?
|
Afghanistan | 1 | 2017 | 78 | 0.030 |
Why?
|
Heating | 1 | 2017 | 103 | 0.030 |
Why?
|
Diagnostic Tests, Routine | 1 | 2002 | 789 | 0.030 |
Why?
|
Rhode Island | 1 | 2017 | 351 | 0.030 |
Why?
|
Body Weights and Measures | 1 | 2017 | 208 | 0.030 |
Why?
|
Lipopolysaccharides | 2 | 2006 | 2215 | 0.030 |
Why?
|
Cyclins | 1 | 2019 | 604 | 0.030 |
Why?
|
Receptors, Cytoplasmic and Nuclear | 1 | 2021 | 857 | 0.030 |
Why?
|
Gene Regulatory Networks | 2 | 2016 | 1752 | 0.030 |
Why?
|
Cation Transport Proteins | 1 | 2019 | 325 | 0.030 |
Why?
|
Quality of Life | 3 | 2024 | 13472 | 0.030 |
Why?
|
Sensitivity and Specificity | 3 | 2013 | 14643 | 0.030 |
Why?
|
Netherlands | 1 | 2021 | 2277 | 0.030 |
Why?
|
Histone Code | 1 | 2017 | 160 | 0.030 |
Why?
|
Middle East | 1 | 2017 | 234 | 0.030 |
Why?
|
Methyltransferases | 1 | 2019 | 373 | 0.030 |
Why?
|
Membrane Proteins | 1 | 2013 | 7866 | 0.030 |
Why?
|
Estrogens | 1 | 2022 | 1528 | 0.030 |
Why?
|
Dyspnea | 1 | 2024 | 1350 | 0.030 |
Why?
|
Dietary Supplements | 2 | 2019 | 3428 | 0.030 |
Why?
|
Abnormalities, Multiple | 1 | 2003 | 1424 | 0.030 |
Why?
|
Diabetes Mellitus | 3 | 2012 | 5883 | 0.030 |
Why?
|
Deoxyguanosine | 1 | 2016 | 96 | 0.030 |
Why?
|
New Jersey | 1 | 2016 | 296 | 0.030 |
Why?
|
Israel | 1 | 2018 | 722 | 0.030 |
Why?
|
Sperm Count | 1 | 2016 | 227 | 0.030 |
Why?
|
Monte Carlo Method | 2 | 2012 | 1249 | 0.030 |
Why?
|
Cats | 1 | 2017 | 972 | 0.030 |
Why?
|
Urbanization | 1 | 2016 | 100 | 0.030 |
Why?
|
Brain Neoplasms | 3 | 2012 | 9101 | 0.030 |
Why?
|
Receptors, Tumor Necrosis Factor, Type II | 1 | 2017 | 347 | 0.030 |
Why?
|
Health Services Accessibility | 1 | 2013 | 5509 | 0.030 |
Why?
|
Wavelet Analysis | 1 | 2015 | 56 | 0.030 |
Why?
|
Prognosis | 2 | 2015 | 29922 | 0.030 |
Why?
|
Ions | 1 | 2016 | 254 | 0.030 |
Why?
|
Skin Tests | 1 | 2017 | 630 | 0.030 |
Why?
|
Immunity | 1 | 2021 | 1002 | 0.030 |
Why?
|
Stochastic Processes | 1 | 1996 | 359 | 0.030 |
Why?
|
Uterine Neoplasms | 1 | 2024 | 1424 | 0.030 |
Why?
|
Uric Acid | 1 | 2021 | 809 | 0.030 |
Why?
|
Maternal Age | 1 | 2018 | 804 | 0.030 |
Why?
|
Bronchodilator Agents | 1 | 2018 | 513 | 0.030 |
Why?
|
Veterans Health | 1 | 2016 | 216 | 0.030 |
Why?
|
Time | 1 | 2016 | 550 | 0.030 |
Why?
|
Oral Health | 1 | 2020 | 493 | 0.030 |
Why?
|
Pipecolic Acids | 1 | 1995 | 77 | 0.030 |
Why?
|
Task Performance and Analysis | 1 | 2019 | 771 | 0.030 |
Why?
|
Subarachnoid Hemorrhage | 1 | 1982 | 1023 | 0.030 |
Why?
|
False Positive Reactions | 1 | 2017 | 957 | 0.030 |
Why?
|
North Carolina | 4 | 2007 | 329 | 0.030 |
Why?
|
Semen Analysis | 1 | 2016 | 235 | 0.030 |
Why?
|
Blood Chemical Analysis | 1 | 2016 | 434 | 0.030 |
Why?
|
Sleep | 1 | 2010 | 4815 | 0.030 |
Why?
|
Demography | 1 | 2019 | 1641 | 0.030 |
Why?
|
Gambia | 1 | 2014 | 104 | 0.030 |
Why?
|
Adaptive Immunity | 1 | 2019 | 733 | 0.030 |
Why?
|
Alu Elements | 1 | 2014 | 115 | 0.030 |
Why?
|
Vitamin E | 1 | 2018 | 873 | 0.030 |
Why?
|
Pulmonary Artery | 1 | 2002 | 1938 | 0.030 |
Why?
|
Indians, North American | 1 | 2017 | 354 | 0.030 |
Why?
|
Siblings | 1 | 2018 | 828 | 0.030 |
Why?
|
Pregnancy Trimester, Second | 1 | 2016 | 737 | 0.030 |
Why?
|
Motor Skills | 1 | 2016 | 519 | 0.030 |
Why?
|
Erythrocytes | 1 | 2023 | 2412 | 0.030 |
Why?
|
Infectious Disease Transmission, Vertical | 1 | 2020 | 1354 | 0.030 |
Why?
|
Mice | 6 | 2022 | 81863 | 0.030 |
Why?
|
Observer Variation | 2 | 2013 | 2613 | 0.030 |
Why?
|
Cyprus | 1 | 2013 | 96 | 0.030 |
Why?
|
Public Health Administration | 1 | 2015 | 242 | 0.030 |
Why?
|
Poisson Distribution | 1 | 2014 | 507 | 0.030 |
Why?
|
Inflammatory Bowel Diseases | 2 | 2018 | 2432 | 0.030 |
Why?
|
China | 1 | 2019 | 2383 | 0.030 |
Why?
|
Gas Chromatography-Mass Spectrometry | 1 | 2013 | 355 | 0.030 |
Why?
|
Organic Chemicals | 1 | 2013 | 211 | 0.030 |
Why?
|
Intracranial Aneurysm | 1 | 1982 | 1271 | 0.030 |
Why?
|
Parents | 2 | 2018 | 3595 | 0.030 |
Why?
|
Registries | 2 | 2019 | 8344 | 0.030 |
Why?
|
Life Style | 1 | 2024 | 3926 | 0.020 |
Why?
|
Texas | 1 | 2013 | 410 | 0.020 |
Why?
|
Long Interspersed Nucleotide Elements | 1 | 2014 | 332 | 0.020 |
Why?
|
Carbamazepine | 2 | 2005 | 224 | 0.020 |
Why?
|
Retrospective Studies | 6 | 2024 | 81588 | 0.020 |
Why?
|
Base Composition | 1 | 2012 | 291 | 0.020 |
Why?
|
Proteoglycans | 1 | 2015 | 806 | 0.020 |
Why?
|
Health Services | 1 | 2017 | 755 | 0.020 |
Why?
|
Comorbidity | 2 | 2017 | 10579 | 0.020 |
Why?
|
Thromboplastin | 1 | 2014 | 289 | 0.020 |
Why?
|
Supreme Court Decisions | 1 | 2013 | 135 | 0.020 |
Why?
|
Thiobarbituric Acid Reactive Substances | 1 | 2011 | 45 | 0.020 |
Why?
|
Behavioral Risk Factor Surveillance System | 1 | 2013 | 212 | 0.020 |
Why?
|
Plethysmography, Whole Body | 1 | 2011 | 25 | 0.020 |
Why?
|
Toll-Like Receptor 2 | 1 | 2014 | 347 | 0.020 |
Why?
|
Blood Flow Velocity | 1 | 2015 | 1374 | 0.020 |
Why?
|
Age Distribution | 1 | 2017 | 2868 | 0.020 |
Why?
|
Pandemics | 2 | 2022 | 8729 | 0.020 |
Why?
|
Wounds, Gunshot | 1 | 2017 | 586 | 0.020 |
Why?
|
Adenomatous Polyposis Coli Protein | 1 | 2012 | 182 | 0.020 |
Why?
|
Anti-Inflammatory Agents | 1 | 2021 | 1805 | 0.020 |
Why?
|
T-Lymphocytes, Helper-Inducer | 1 | 2017 | 975 | 0.020 |
Why?
|
Intra-Abdominal Fat | 1 | 2016 | 624 | 0.020 |
Why?
|
Species Specificity | 2 | 2010 | 2413 | 0.020 |
Why?
|
Mathematical Computing | 1 | 2011 | 142 | 0.020 |
Why?
|
New York City | 1 | 2013 | 736 | 0.020 |
Why?
|
Ultrasonography, Doppler | 1 | 2013 | 464 | 0.020 |
Why?
|
Spectrometry, X-Ray Emission | 1 | 2011 | 144 | 0.020 |
Why?
|
New York | 4 | 2004 | 879 | 0.020 |
Why?
|
Oximetry | 1 | 2014 | 461 | 0.020 |
Why?
|
Cognition Disorders | 1 | 2005 | 3967 | 0.020 |
Why?
|
Genomics | 1 | 2006 | 5924 | 0.020 |
Why?
|
Glomerular Filtration Rate | 1 | 2019 | 2230 | 0.020 |
Why?
|
Creatinine | 1 | 2016 | 1916 | 0.020 |
Why?
|
Half-Life | 1 | 2011 | 648 | 0.020 |
Why?
|
Morbidity | 1 | 2015 | 1753 | 0.020 |
Why?
|
Vascular Resistance | 1 | 2013 | 939 | 0.020 |
Why?
|
Models, Chemical | 1 | 2012 | 607 | 0.020 |
Why?
|
Lipids | 2 | 2016 | 3319 | 0.020 |
Why?
|
Spores, Fungal | 1 | 2010 | 89 | 0.020 |
Why?
|
Age of Onset | 1 | 2017 | 3342 | 0.020 |
Why?
|
Fasting | 1 | 2016 | 1609 | 0.020 |
Why?
|
Child Welfare | 1 | 2014 | 521 | 0.020 |
Why?
|
Luminescent Measurements | 1 | 2011 | 341 | 0.020 |
Why?
|
Homocystine | 1 | 1989 | 21 | 0.020 |
Why?
|
Receptors, N-Methyl-D-Aspartate | 1 | 1995 | 903 | 0.020 |
Why?
|
Hyperglycemia | 1 | 2018 | 1389 | 0.020 |
Why?
|
Filtration | 1 | 2010 | 227 | 0.020 |
Why?
|
Nitric Oxide Synthase Type III | 1 | 2012 | 707 | 0.020 |
Why?
|
Protein Processing, Post-Translational | 1 | 2017 | 1963 | 0.020 |
Why?
|
Feedback | 1 | 2013 | 797 | 0.020 |
Why?
|
Epilepsy | 2 | 2002 | 3317 | 0.020 |
Why?
|
Cyclin-Dependent Kinase Inhibitor p16 | 1 | 2012 | 703 | 0.020 |
Why?
|
Databases, Genetic | 1 | 2016 | 1755 | 0.020 |
Why?
|
DNA Copy Number Variations | 1 | 2017 | 2043 | 0.020 |
Why?
|
Influenza, Human | 1 | 2000 | 1542 | 0.020 |
Why?
|
Public Health | 2 | 2015 | 2681 | 0.020 |
Why?
|
Metabolic Networks and Pathways | 1 | 2013 | 800 | 0.020 |
Why?
|
San Francisco | 1 | 2008 | 165 | 0.020 |
Why?
|
Markov Chains | 1 | 2012 | 974 | 0.020 |
Why?
|
Insulin | 1 | 2023 | 6608 | 0.020 |
Why?
|
Up-Regulation | 1 | 2017 | 4141 | 0.020 |
Why?
|
Bronchiolitis | 1 | 2014 | 492 | 0.020 |
Why?
|
Lymphocyte Activation | 1 | 2019 | 5502 | 0.020 |
Why?
|
History, 21st Century | 1 | 2014 | 1574 | 0.020 |
Why?
|
Random Allocation | 1 | 2012 | 2393 | 0.020 |
Why?
|
Survival Analysis | 2 | 2012 | 10092 | 0.020 |
Why?
|
Mice, Inbred BALB C | 2 | 2010 | 6217 | 0.020 |
Why?
|
Floors and Floorcoverings | 1 | 2007 | 27 | 0.020 |
Why?
|
Weights and Measures | 1 | 2007 | 40 | 0.020 |
Why?
|
Oligonucleotide Array Sequence Analysis | 1 | 2016 | 3795 | 0.020 |
Why?
|
Autonomic Nervous System Diseases | 1 | 2010 | 269 | 0.020 |
Why?
|
Cadherins | 1 | 2012 | 901 | 0.020 |
Why?
|
Endarterectomy, Carotid | 1 | 2013 | 556 | 0.020 |
Why?
|
Beds | 1 | 2007 | 48 | 0.020 |
Why?
|
Sputum | 1 | 2010 | 513 | 0.020 |
Why?
|
Body Weight | 1 | 2018 | 4625 | 0.020 |
Why?
|
Antigens, Plant | 1 | 2007 | 104 | 0.020 |
Why?
|
Telomerase | 1 | 2012 | 750 | 0.020 |
Why?
|
Histological Techniques | 1 | 2007 | 193 | 0.020 |
Why?
|
Heart Function Tests | 1 | 2008 | 316 | 0.020 |
Why?
|
Missouri | 1 | 2007 | 113 | 0.020 |
Why?
|
Small-Area Analysis | 1 | 2006 | 51 | 0.020 |
Why?
|
Genotype | 2 | 2013 | 13034 | 0.020 |
Why?
|
Mice, Inbred AKR | 1 | 2006 | 103 | 0.020 |
Why?
|
Hearing Loss | 1 | 2014 | 785 | 0.020 |
Why?
|
Homeostasis | 1 | 2017 | 3341 | 0.020 |
Why?
|
Genome, Human | 1 | 2019 | 4443 | 0.020 |
Why?
|
Deferoxamine | 1 | 2006 | 155 | 0.020 |
Why?
|
History, 20th Century | 1 | 2014 | 2764 | 0.020 |
Why?
|
Learning | 1 | 2015 | 1754 | 0.020 |
Why?
|
Image Processing, Computer-Assisted | 1 | 2003 | 8925 | 0.020 |
Why?
|
NF-kappa B | 1 | 2014 | 2495 | 0.020 |
Why?
|
Acute Coronary Syndrome | 2 | 2009 | 2184 | 0.020 |
Why?
|
Homocysteine | 1 | 1989 | 638 | 0.020 |
Why?
|
Depressive Disorder | 1 | 2018 | 3714 | 0.020 |
Why?
|
Monitoring, Physiologic | 1 | 2013 | 1794 | 0.020 |
Why?
|
Respiratory Mechanics | 1 | 2010 | 719 | 0.020 |
Why?
|
Aspartic Acid Endopeptidases | 1 | 2007 | 308 | 0.020 |
Why?
|
Carotid Stenosis | 1 | 2013 | 858 | 0.020 |
Why?
|
Rats, Inbred Strains | 1 | 2006 | 2078 | 0.020 |
Why?
|
Models, Neurological | 1 | 2013 | 1747 | 0.020 |
Why?
|
Interferon-gamma | 1 | 2014 | 3159 | 0.020 |
Why?
|
Transportation | 1 | 2007 | 217 | 0.020 |
Why?
|
Oxidation-Reduction | 1 | 2011 | 2223 | 0.020 |
Why?
|
Ventilation | 1 | 2006 | 129 | 0.020 |
Why?
|
Arterial Occlusive Diseases | 1 | 1989 | 742 | 0.020 |
Why?
|
Angina, Unstable | 1 | 2009 | 893 | 0.020 |
Why?
|
Mice, Inbred C3H | 1 | 2006 | 915 | 0.010 |
Why?
|
DNA Repair | 1 | 2014 | 2048 | 0.010 |
Why?
|
Antidepressive Agents | 1 | 2017 | 2902 | 0.010 |
Why?
|
Twins, Dizygotic | 1 | 2005 | 236 | 0.010 |
Why?
|
Cardiac Complexes, Premature | 1 | 2004 | 63 | 0.010 |
Why?
|
Alleles | 1 | 2016 | 6894 | 0.010 |
Why?
|
Rivers | 1 | 2004 | 65 | 0.010 |
Why?
|
Coronary Angiography | 1 | 2016 | 4497 | 0.010 |
Why?
|
Loss of Heterozygosity | 1 | 2006 | 663 | 0.010 |
Why?
|
Diagnosis-Related Groups | 1 | 1986 | 445 | 0.010 |
Why?
|
DNA, Neoplasm | 1 | 2009 | 1741 | 0.010 |
Why?
|
Chile | 1 | 2005 | 258 | 0.010 |
Why?
|
Polymorphism, Genetic | 1 | 2014 | 4249 | 0.010 |
Why?
|
Cost-Benefit Analysis | 1 | 2017 | 5535 | 0.010 |
Why?
|
Facies | 1 | 2005 | 224 | 0.010 |
Why?
|
Infant, Premature | 1 | 2014 | 2121 | 0.010 |
Why?
|
Cytokines | 1 | 2019 | 7436 | 0.010 |
Why?
|
Biological Availability | 1 | 2004 | 387 | 0.010 |
Why?
|
Chemistry, Physical | 1 | 2003 | 152 | 0.010 |
Why?
|
Intelligence Tests | 1 | 2005 | 504 | 0.010 |
Why?
|
Twins, Monozygotic | 1 | 2005 | 471 | 0.010 |
Why?
|
Polymerase Chain Reaction | 1 | 2013 | 6061 | 0.010 |
Why?
|
Mutation | 2 | 2021 | 30220 | 0.010 |
Why?
|
Circadian Rhythm | 1 | 2015 | 2592 | 0.010 |
Why?
|
Chemical Phenomena | 1 | 2003 | 485 | 0.010 |
Why?
|
Mental Health | 1 | 2018 | 3270 | 0.010 |
Why?
|
Colony Count, Microbial | 1 | 2003 | 326 | 0.010 |
Why?
|
Polysomnography | 1 | 2010 | 1868 | 0.010 |
Why?
|
Dose-Response Relationship, Drug | 2 | 2008 | 10740 | 0.010 |
Why?
|
Acute Disease | 2 | 2009 | 7240 | 0.010 |
Why?
|
Hydrogen Peroxide | 1 | 2006 | 741 | 0.010 |
Why?
|
Image Enhancement | 1 | 2013 | 2856 | 0.010 |
Why?
|
Blood Gas Analysis | 1 | 2004 | 382 | 0.010 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 1 | 2010 | 3803 | 0.010 |
Why?
|
Liver Neoplasms | 1 | 2018 | 4356 | 0.010 |
Why?
|
Double-Blind Method | 2 | 2013 | 12423 | 0.010 |
Why?
|
Caseins | 1 | 2003 | 105 | 0.010 |
Why?
|
Polyethylene | 1 | 2004 | 186 | 0.010 |
Why?
|
Coronary Disease | 2 | 2012 | 5914 | 0.010 |
Why?
|
Feasibility Studies | 1 | 2013 | 5302 | 0.010 |
Why?
|
Injections, Intraperitoneal | 1 | 2003 | 410 | 0.010 |
Why?
|
Angioplasty, Balloon, Coronary | 1 | 2009 | 1721 | 0.010 |
Why?
|
Gene Deletion | 1 | 2010 | 2668 | 0.010 |
Why?
|
Genes, Tumor Suppressor | 1 | 2006 | 1058 | 0.010 |
Why?
|
Membranes, Artificial | 1 | 2004 | 362 | 0.010 |
Why?
|
Food | 1 | 2007 | 764 | 0.010 |
Why?
|
Solubility | 1 | 2004 | 1078 | 0.010 |
Why?
|
Tumor Suppressor Proteins | 1 | 2012 | 2799 | 0.010 |
Why?
|
Dose-Response Relationship, Immunologic | 1 | 2002 | 360 | 0.010 |
Why?
|
Base Sequence | 1 | 2013 | 12412 | 0.010 |
Why?
|
Oregon | 3 | 1986 | 148 | 0.010 |
Why?
|
Bronchial Hyperreactivity | 1 | 2003 | 299 | 0.010 |
Why?
|
Tumor Suppressor Protein p53 | 1 | 2012 | 2947 | 0.010 |
Why?
|
Epiphyses | 1 | 2002 | 191 | 0.010 |
Why?
|
Respiratory Hypersensitivity | 1 | 2003 | 271 | 0.010 |
Why?
|
Spleen | 1 | 2007 | 2294 | 0.010 |
Why?
|
Ovalbumin | 1 | 2003 | 676 | 0.010 |
Why?
|
Genetic Predisposition to Disease | 1 | 2023 | 18075 | 0.010 |
Why?
|
Antibody Specificity | 1 | 2003 | 1062 | 0.010 |
Why?
|
Models, Animal | 1 | 2007 | 2119 | 0.010 |
Why?
|
Health Status | 1 | 2014 | 4085 | 0.010 |
Why?
|
Travel | 1 | 2006 | 806 | 0.010 |
Why?
|
Bronchoalveolar Lavage | 1 | 2000 | 131 | 0.010 |
Why?
|
Genetic Markers | 1 | 2006 | 2603 | 0.010 |
Why?
|
Gene Expression | 1 | 2013 | 7583 | 0.010 |
Why?
|
Neoplasm Proteins | 1 | 2012 | 3601 | 0.010 |
Why?
|
Gene Expression Profiling | 1 | 2016 | 9521 | 0.010 |
Why?
|
Tissue Distribution | 1 | 2004 | 2275 | 0.010 |
Why?
|
Atmosphere Exposure Chambers | 1 | 1999 | 51 | 0.010 |
Why?
|
Predictive Value of Tests | 1 | 2016 | 15390 | 0.010 |
Why?
|
Mice, Inbred C57BL | 2 | 2010 | 22337 | 0.010 |
Why?
|
Pulmonary Alveoli | 1 | 2002 | 665 | 0.010 |
Why?
|
Diet | 1 | 2017 | 8085 | 0.010 |
Why?
|
Administration, Inhalation | 1 | 2002 | 1154 | 0.010 |
Why?
|
Specimen Handling | 1 | 2003 | 706 | 0.010 |
Why?
|
Area Under Curve | 1 | 2002 | 1638 | 0.010 |
Why?
|
Adrenergic beta-Antagonists | 1 | 2004 | 1236 | 0.010 |
Why?
|
Valproic Acid | 1 | 2001 | 444 | 0.010 |
Why?
|
L-Lactate Dehydrogenase | 1 | 1999 | 411 | 0.010 |
Why?
|
Water | 1 | 2004 | 1417 | 0.010 |
Why?
|
Reference Values | 1 | 2004 | 4913 | 0.010 |
Why?
|
Cell Survival | 1 | 2006 | 5741 | 0.010 |
Why?
|
Epitopes | 1 | 2003 | 2526 | 0.010 |
Why?
|
Coronary Vessels | 1 | 2007 | 3094 | 0.010 |
Why?
|
Cholesterol, LDL | 1 | 2005 | 2392 | 0.010 |
Why?
|
Immunity, Cellular | 1 | 2000 | 1560 | 0.010 |
Why?
|
Skin Neoplasms | 1 | 2014 | 5860 | 0.010 |
Why?
|
Phagocytosis | 1 | 1999 | 1527 | 0.010 |
Why?
|
Stroke Volume | 1 | 2007 | 5583 | 0.010 |
Why?
|
Injections, Intravenous | 1 | 1995 | 1377 | 0.010 |
Why?
|
Excitatory Amino Acid Antagonists | 1 | 1995 | 451 | 0.010 |
Why?
|
Severity of Illness Index | 1 | 2010 | 15897 | 0.010 |
Why?
|
Coma | 2 | 1986 | 485 | 0.010 |
Why?
|
Kidney | 1 | 2007 | 7071 | 0.010 |
Why?
|
Liver | 1 | 2007 | 7570 | 0.010 |
Why?
|
Cells, Cultured | 1 | 2006 | 18979 | 0.010 |
Why?
|
Ultrasonography | 1 | 2002 | 5988 | 0.010 |
Why?
|
Flow Cytometry | 1 | 1999 | 5890 | 0.000 |
Why?
|
Central Nervous System | 1 | 1995 | 1345 | 0.000 |
Why?
|
Ovarian Neoplasms | 1 | 2002 | 4904 | 0.000 |
Why?
|
Chromatography, High Pressure Liquid | 1 | 1989 | 1528 | 0.000 |
Why?
|
Chronic Disease | 1 | 1999 | 9352 | 0.000 |
Why?
|
Cerebral Infarction | 1 | 1986 | 967 | 0.000 |
Why?
|
Ischemic Attack, Transient | 1 | 1986 | 872 | 0.000 |
Why?
|
Employment | 1 | 1986 | 1110 | 0.000 |
Why?
|
Tomography, X-Ray Computed | 1 | 2002 | 20706 | 0.000 |
Why?
|
Diabetes Complications | 1 | 1986 | 1317 | 0.000 |
Why?
|
Activities of Daily Living | 1 | 1986 | 2429 | 0.000 |
Why?
|
Magnetic Resonance Imaging | 1 | 2002 | 36562 | 0.000 |
Why?
|
Cerebral Hemorrhage | 1 | 1986 | 2654 | 0.000 |
Why?
|